JANX
Income statement / Annual
Last year (2023), Janux Therapeutics, Inc.'s total revenue was $8.08 M,
a decrease of 6.14% from the previous year.
In 2023, Janux Therapeutics, Inc.'s net income was -$58.29 M.
See Janux Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$8.08 M
|
$8.61 M
|
$3.64 M
|
$0.00
|
$0.00
|
| Cost of Revenue |
$54.92 M |
$841,000.00 |
$113,000.00 |
$13,000.00 |
$6,000.00 |
| Gross Profit |
-$46.84 M |
$7.77 M |
$3.52 M |
-$13,000.00 |
-$6,000.00 |
| Gross Profit Ratio |
-5.79 |
0.9 |
0.97 |
0 |
0 |
| Research and Development
Expenses |
$54.92 M
|
$53.44 M
|
$26.24 M
|
$3.04 M
|
$3.00 M
|
| General & Administrative
Expenses |
$26.14 M
|
$22.26 M
|
$10.33 M
|
$1.80 M
|
$772,000.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$26.14 M
|
$22.26 M
|
$10.33 M
|
$1.80 M
|
$772,000.00
|
| Other Expenses |
$0.00 |
$4.03 M |
$257,000.00 |
-$1.74 M |
$0.00 |
| Operating Expenses |
$81.06 M |
$75.70 M |
$36.57 M |
$4.84 M |
$3.77 M |
| Cost And Expenses |
$81.06 M |
$75.70 M |
$36.57 M |
$4.84 M |
$3.77 M |
| Interest Income |
$14.69 M |
$4.03 M |
$257,000.00 |
$206,000.00 |
$233,000.00 |
| Interest Expense |
$0.00 |
$4.03 M |
$0.00 |
$206,000.00 |
$233,000.00 |
| Depreciation &
Amortization |
$1.96 M
|
$841,000.00
|
$113,000.00
|
$13,000.00
|
$6,000.00
|
| EBITDA |
-$71.02 M
|
-$66.25 M
|
-$32.82 M
|
-$4.83 M
|
-$3.77 M
|
| EBITDA Ratio |
-8.79 |
-7.79 |
-9.05 |
0 |
0 |
| Operating Income Ratio
|
-9.03
|
-7.79
|
-9.05
|
0
|
0
|
| Total Other
Income/Expenses Net |
$14.69 M
|
$4.03 M
|
$257,000.00
|
-$1.94 M
|
-$233,000.00
|
| Income Before Tax |
-$58.29 M |
-$63.06 M |
-$32.67 M |
-$6.78 M |
-$4.00 M |
| Income Before Tax Ratio
|
-7.21
|
-7.32
|
-8.98
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$8.91 M |
-$113,000.00 |
-$1.53 M |
$233,000.00 |
| Net Income |
-$58.29 M |
-$54.15 M |
-$32.56 M |
-$5.26 M |
-$4.24 M |
| Net Income Ratio |
-7.21 |
-6.29 |
-8.95 |
0 |
0 |
| EPS |
-1.32 |
-1.31 |
-0.79 |
-0.13 |
-0.1 |
| EPS Diluted |
-1.32 |
-1.31 |
-0.79 |
-0.13 |
-0.1 |
| Weighted Average Shares
Out |
$44.02 M
|
$41.47 M
|
$41.24 M
|
$41.61 M
|
$41.61 M
|
| Weighted Average Shares
Out Diluted |
$44.02 M
|
$41.47 M
|
$41.24 M
|
$41.61 M
|
$41.61 M
|
| Link |
|
|
|
|
|
